ArteraAI Company
The ArteraAI Prostate Test is intended to identify patients who will benefit from therapy intensification and help guide treatment decisions for men with localized prostate cancer. By learning from digital pathology images and ingesting clinical data, our test can predict therapy benefit and determine prognosis for a patient.
Headquarters:
United States
Employee Number:
101-250
Technology:
['BioTech & HealthTech']
Industry:
HealthCare Administration